Virpax Pharmaceuticals (VRPX) Q2 2024 Earnings

13MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-2.75
-1.83
-0.92
0

Details

Expected EPS
N/A
Actual EPS
-2.75
Surprise EPS
-2.75
Surprise Percent
+∞%

Description

Virpax Pharmaceuticals (VRPX) has reported earnings of -2.75 per share for Q2 2024.

0 Comments

Share your thoughts